bosentan anhydrous has been researched along with Dyspnea in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, S; Hirashiki, A; Kondo, T; Matsubara, H; Miyaji, K; Murohara, T; Nakaguro, M; Ogawa, A; Yokoi, T | 1 |
| Cassandro, R; Confalonieri, M; Harari, S; Kodric, M; Piattella, M; Potena, A; Scarda, A; Scarduelli, C; Vassallo, FG | 1 |
| Baldi, S; D'Angelo, S; Naclerio, C; Scarpato, S; Tagliamonte, G | 1 |
| Behr, J; Brown, KK; du Bois, RM; King, TE; Leconte, I; Raghu, G; Roux, S; Swigris, J | 1 |
| Janda, S; Quon, BS; Swiston, J | 1 |
| Dunnington, GH; Johri, S; Vnencak-Jones, CL | 1 |
| Cordier, JF; Cottin, V; Etienne-Mastroïanni, B; Humbert, M; Khouatra, C; Kiakouama, L | 1 |
| Kähler, CM | 1 |
| Israël-Biet, D; Lerolle, U; Marié, E; Meyer, G; Sanchez, O; Wermert, D | 1 |
| Clarke, B; Hadi, H; Hamid, T; Mahadevan, V | 1 |
| Cai, Y; Guo, F; Kuang, JL; Yan, CS; Ye, XQ; Zhang, XY | 1 |
| Caballero Eraso, C; Elías Hernández, T; Ferrer Galván, M; Jara Palomares, L; López Villalobos, JL; Otero Candelera, R | 1 |
| Daniels, CJ | 1 |
| Pereira, BN; Salvi, S | 1 |
| Dingemanse, J; Giersbergen, PL; Izumi, T; Kunieda, T; Kuriyama, T; Matsuzaki, M; Origasa, H; Sasayama, S; Shirato, K; Tanaka, S; Tomoike, H | 1 |
| Badesch, D; Barst, RJ; Frost, A; Galie, N; Langleben, D; Lawrence, EC; Naeije, R; Shapiro, S | 1 |
| Gabbay, E; Reed, A; Williams, TJ | 1 |
| Distler, JH; Distler, O; Hoeper, MM | 1 |
| Benza, RL; Bourge, RC; Pamboukian, SV; Rayburn, BK; Tallaj, JA | 1 |
4 review(s) available for bosentan anhydrous and Dyspnea
| Article | Year |
|---|---|
HIV and pulmonary arterial hypertension: a systematic review.
Topics: Adolescent; Adult; Antihypertensive Agents; Antiretroviral Therapy, Highly Active; Bosentan; Cardiomegaly; CD4 Lymphocyte Count; Child; Cohort Studies; Confounding Factors, Epidemiologic; Databases, Bibliographic; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Echocardiography; Electrocardiography; Epoprostenol; Female; Hemodynamics; HIV Infections; Humans; Hypertension, Pulmonary; Male; Prevalence; Radiography; Reverse Transcriptase Inhibitors; Sulfonamides; Survival Rate; Treatment Outcome | 2010 |
Pulmonary arterial hypertension in women.
Topics: Abortion, Therapeutic; Adult; Anticoagulants; Bone Morphogenetic Protein Receptors, Type II; Bosentan; Calcium Channel Blockers; Contraception; Dyspnea; Endothelin A Receptor Antagonists; Female; Fetal Growth Retardation; Genetic Predisposition to Disease; Humans; Hypertension, Pulmonary; Infant, Newborn; Male; Middle Aged; Phosphodiesterase Inhibitors; Pregnancy; Pregnancy Complications, Cardiovascular; Preimplantation Diagnosis; Prognosis; Prostaglandins I; Sex Distribution; Sulfonamides; Ultrasonography | 2010 |
Lengthy diagnostic challenge in a rare case of pulmonary veno-occlusive disease: case report and review of the literature.
Topics: Adult; Antihypertensive Agents; Biopsy; Bosentan; Cardiotonic Agents; Diagnosis, Differential; Digoxin; Diuretics; Drug Therapy, Combination; Dyspnea; Humans; Hypertension, Pulmonary; Male; Pulmonary Heart Disease; Pulmonary Veno-Occlusive Disease; Sulfonamides; Time Factors; Tomography, X-Ray Computed | 2011 |
Assessment and treatment of pulmonary arterial hypertension: an Australian perspective in 2006.
Topics: Adolescent; Adult; Aged; Arterioles; Australia; Bosentan; Cardiac Catheterization; Diagnostic Imaging; Disease Progression; Dyspnea; Endothelin A Receptor Antagonists; Epoprostenol; Exercise Test; Female; Forecasting; Heart-Lung Transplantation; Humans; Hypertension, Pulmonary; Iloprost; Lung Transplantation; Male; Middle Aged; Nitric Oxide; Piperazines; Prognosis; Pulmonary Artery; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfonamides; Sulfones; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Right | 2007 |
4 trial(s) available for bosentan anhydrous and Dyspnea
| Article | Year |
|---|---|
Bosentan for patients with chronic thromboembolic pulmonary hypertension.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Bosentan; Chronic Disease; Diuretics; Drug Therapy, Combination; Dyspnea; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Prospective Studies; Pulmonary Embolism; Sulfonamides; Treatment Outcome; Walking; Young Adult | 2009 |
Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1).
Topics: Bosentan; Dyspnea; Humans; Pulmonary Fibrosis; Quality of Life; Sulfonamides | 2010 |
Effects of the endothelin receptor antagonist bosentan on hemodynamics, symptoms and functional capacity in Japanese patients with severe pulmonary hypertension.
Topics: Adult; Asian People; Blood Pressure; Bosentan; Cardiac Output; Dyspnea; Endothelin Receptor Antagonists; Exercise Test; Hemodynamics; Humans; Hypertension, Pulmonary; Pharmacokinetics; Quality of Life; Sulfonamides; Vascular Resistance; White People | 2005 |
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Bosentan; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Dyspnea; Endothelin A Receptor Antagonists; Exercise Test; Exercise Tolerance; Female; Health Status Indicators; Hemodynamics; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Middle Aged; Risk Assessment; Sulfonamides; Thiophenes; Treatment Outcome | 2006 |
13 other study(ies) available for bosentan anhydrous and Dyspnea
| Article | Year |
|---|---|
Imatinib is partially effective for the treatment of pulmonary capillary hemangiomatosis.
Topics: Adult; Antihypertensive Agents; Antineoplastic Agents; Autopsy; Benzamides; Bosentan; Cardiac Catheterization; Dyspnea; Echocardiography; Epoprostenol; Fatal Outcome; Hemangioma, Capillary; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Lung; Lung Neoplasms; Male; Piperazines; Purines; Pyrimidines; Radiography, Thoracic; Sildenafil Citrate; Sulfonamides; Treatment Failure | 2014 |
Efficacy of bosentan in the treatment of a patient with mixed connective tissue disease complicated by pulmonary arterial hypertension.
Topics: Adult; Antihypertensive Agents; Bosentan; Dyspnea; Echocardiography; Female; Humans; Hypertension, Pulmonary; Mixed Connective Tissue Disease; Sulfonamides; Treatment Outcome | 2010 |
A novel BMPR2 mutation associated with pulmonary arterial hypertension in an octogenarian.
Topics: Aged, 80 and over; Amlodipine; Bone Morphogenetic Protein Receptors, Type II; Bosentan; Digoxin; Dyspnea; Humans; Hypertension, Pulmonary; Male; Pulmonary Artery; Sulfonamides; Warfarin | 2010 |
Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentan.
Topics: Antihypertensive Agents; Bosentan; Dyspnea; Hemodynamics; Histiocytosis, Langerhans-Cell; Humans; Hypertension, Pulmonary; Male; Middle Aged; Piperazines; Purines; Severity of Illness Index; Sildenafil Citrate; Sulfonamides; Sulfones | 2010 |
Chronic thromboembolic pulmonary hypertension as a cause of dyspnoea in an older patient with a complex history.
Topics: Antihypertensive Agents; Bosentan; Chronic Disease; Dyspnea; Endarterectomy; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Embolism; Sulfonamides; Tomography, Spiral Computed | 2009 |
The pressure wire as a diagnostic tool in patients with congenital cardiac disease.
Topics: Adult; Antihypertensive Agents; Bosentan; Cardiac Catheterization; Dyspnea; Female; Heart Defects, Congenital; Heart Valve Prosthesis; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Sulfonamides; Young Adult | 2011 |
Chronic thromboembolic pulmonary hypertension due to upper-extremity deep vein thrombosis caused by thoracic outlet syndrome.
Topics: Antihypertensive Agents; Arm; Asthma; Bosentan; Cardiac Catheterization; Dyspnea; Female; Humans; Hypertension, Pulmonary; Pulmonary Embolism; Smoking; Sulfonamides; Syncope; Thoracic Outlet Syndrome; Thrombophlebitis; Young Adult | 2012 |
Adult congenital heart disease and pulmonary hypertension: management of a complex case.
Topics: Adult; Antihypertensive Agents; Bosentan; Cardiac Catheterization; Disease Progression; Dyspnea; Eisenmenger Complex; Exercise Test; Follow-Up Studies; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; Oxygen; Pulmonary Valve Stenosis; Sulfonamides | 2012 |
Bosentan for pulmonary hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Bosentan; Dose-Response Relationship, Drug; Dyspnea; Exercise Tolerance; Humans; Hypertension, Pulmonary; Pulmonary Artery; Sulfonamides | 2002 |
[Young patient with stress dyspnea of uncertain origin. Evaluate for pulmonary hypertension!].
Topics: Adult; Antihypertensive Agents; Bosentan; Clinical Trials as Topic; Diagnosis, Differential; Dyspnea; Endothelin Receptor Antagonists; Humans; Hypertension, Pulmonary; Male; Physical Exertion; Sulfonamides | 2002 |
[Dyspnea. When is it pulmonary hypertension?].
Topics: Antihypertensive Agents; Bosentan; Diagnosis, Differential; Dyspnea; Endothelin Receptor Antagonists; Humans; Hypertension, Pulmonary; Sulfonamides | 2003 |
Diagnosis of pulmonary arterial hypertension in a patient with systemic sclerosis.
Topics: Adult; Antihypertensive Agents; Bosentan; Dyspnea; Echocardiography; Exercise Test; Female; Humans; Hypertension, Pulmonary; Natriuretic Peptide, Brain; Respiratory Function Tests; Scleroderma, Systemic; Sulfonamides | 2008 |
Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Bosentan; Drug Therapy, Combination; Dyspnea; Epoprostenol; Exercise Tolerance; Female; Humans; Hypertension, Pulmonary; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Sulfonamides | 2008 |